Related references
Note: Only part of the references are listed.GLOBAL ENDOCRINOLOGY: Geographical variation in the profile of RET variants in patients with medullary thyroid cancer: a comprehensive review
Rui M. B. Maciel et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2022)
Germline RET variants underlie a subset of paediatric osteosarcoma
Michal Kovac et al.
JOURNAL OF MEDICAL GENETICS (2021)
Diagnostic RET genetic testing in 1,058 index patients: A UK centre perspective
Jonathan Mark Fussey et al.
CLINICAL ENDOCRINOLOGY (2021)
Genotype and phenotype landscape of MEN2 in 554 medullary thyroid cancer patients: the BrasMEN study
Rui M. B. Maciel et al.
ENDOCRINE CONNECTIONS (2019)
Incidence and prevalence of multiple endocrine neoplasia 2B in Denmark: a nationwide study
Jes Sloth Mathiesen et al.
ENDOCRINE-RELATED CANCER (2017)
Nationwide French Study of RET Variants Detected from 2003 to 2013 Suggests a Possible Influence of Polymorphisms as Modifiers
Maylis Lebeault et al.
THYROID (2017)
Phaeochromocytoma in multiple endocrine neoplasia type 2: RET codon-specific penetrance and changes in management during the last four decades
L. Mucha et al.
CLINICAL ENDOCRINOLOGY (2017)
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
Samuel A. Wells et al.
THYROID (2015)
Papillary thyroid carcinoma and multiple endocrine neoplasia type 2
B. Febrero et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2015)
Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?
Cristina Romei et al.
CLINICAL ENDOCRINOLOGY (2015)
RET Cys634Arg mutation confers a more aggressive multiple endocrine neoplasia type 2A phenotype than Cys634Tyr mutation
Nuria Valdes et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon 634 mutation in Japanese patients
Tsuneo Imai et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Simultaneous Medullary and Papillary Thyroid Cancer: A Novel Entity?
Andreas Machens et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Molecular Basis of Medullary Thyroid Carcinoma: The Role of RET Polymorphisms
Lucieli Ceolin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
RET Proto-Oncogene Genetic Screening of Families with Multiple Endocrine Neoplasia Type 2 Optimizes Diagnostic and Clinical Management in China
Xiao-Ping Qi et al.
THYROID (2012)
Concurrent occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma in the same thyroid should be considered as coincidental
Won Gu Kim et al.
CLINICAL ENDOCRINOLOGY (2010)
Familial prevalence and age of RET germline mutations: implications for screening
Andreas Machens et al.
CLINICAL ENDOCRINOLOGY (2008)
RET proto-oncogene in Sardinia: V804M is the most frequent mutation and may be associated with FMTC/MEN-2A phenotype
Giovanni Pinna et al.
THYROID (2007)
Hereditary medullary thyroid cancer in Slovenia - genotype phenotype correlations
Damijan Bergant et al.
WIENER KLINISCHE WOCHENSCHRIFT (2006)
RET proto-oncogene:: A review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors
MA Kouvaraki et al.
THYROID (2005)
Papillary thyroid carcinoma in patients with RET proto-oncogene germline mutation
M Brauckhoff et al.
THYROID (2002)
Share Paper
